In conclusion, we suggest that MT‐ATP6–related mtDNA disease is best defined as a mitochondrial disease spectrum disorder that includes core clinical features of cerebellar ataxia, peripheral neuropathy, and learning disability, with or without a Leigh‐like phenotype. The gene discussed is MT-ATP6; the disease is peripheral neuropathy.